Pediatrix Medical Group I... (MD)
NYSE: MD
· Real-Time Price · USD
16.05
0.51 (3.28%)
At close: Aug 15, 2025, 3:13 PM
Pediatrix Medical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 224.73M | 98.98M | 229.94M | 103.83M | 19.4M | 8M | 73.26M | 21.18M | 5.85M | 6.12M | 9.82M | 8.67M | 14.09M | 7.18M | 387.39M | 357.91M | 338.16M | 269.63M |
Short-Term Investments | 123.59M | 120.2M | 118.57M | 116.62M | 113.8M | 107.47M | 104.48M | 103.54M | 98.49M | 96.71M | 93.24M | 91.4M | 93.39M | 89.58M | 99.72M | 98.51M | 100.76M | 100.81M |
Long-Term Investments | n/a | n/a | n/a | n/a | 29.4M | -1.5B | 33.2M | 40.6M | 47M | 96.71M | 93.24M | 50.4M | 93.39M | 54.9M | 99.72M | 58.9M | 58.6M | 60.8M |
Other Long-Term Assets | 70.78M | 71.35M | 76.6M | 78.59M | 50.14M | 1.65B | 48.97M | 67.41M | 69.83M | -102.78M | -105.92M | 67.32M | -93.22M | 73.3M | -88.34M | 71.19M | 55.8M | 49.26M |
Receivables | 246.62M | 252.8M | 272.6M | 288.1M | 274.16M | 283.75M | 279.88M | 277.35M | 270.85M | 278.74M | 296.79M | 304.08M | 328.73M | 317.62M | 301.77M | 279.25M | 277.11M | 265.13M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 13.53M | 10.59M | 12.46M | n/a | n/a | 9.66M | n/a | 16.32M | n/a | 12.64M | 18.9M | 19.45M |
Other Current Assets | 7.68M | 7.61M | 5.09M | 9.48M | 9.94M | 14.77M | 12.31M | 7.87M | 10.12M | 12.07M | 13.26M | 9.9M | 8.86M | 9.08M | 33.15M | 39.71M | 17.39M | 10.38M |
Total Current Assets | 613.05M | 491.67M | 639.61M | 528.22M | 429.21M | 426.52M | 483.45M | 420.52M | 397.77M | 311.88M | 334.75M | 423.71M | 365.92M | 439.78M | 740.85M | 788.03M | 752.31M | 665.4M |
Property-Plant & Equipment | 77.63M | 78.09M | 78.44M | 98.49M | 113.28M | 70.28M | 145.93M | 147.59M | 140.42M | 66.79M | 66.92M | 141M | 67.5M | 138.51M | 65.46M | 137.7M | 124.99M | 133.44M |
Goodwill & Intangibles | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.41B | 1.41B | 1.55B | 1.55B | 1.84B | 1.85B | 1.55B | 1.84B | 1.55B | 1.82B | 1.52B | 1.51B | 1.5B |
Total Long-Term Assets | 1.49B | 1.5B | 1.51B | 1.55B | 1.57B | 1.74B | 1.74B | 1.91B | 1.91B | 2.01B | 2.01B | 1.91B | 2B | 1.9B | 1.98B | 1.86B | 1.8B | 1.82B |
Total Assets | 2.1B | 1.99B | 2.15B | 2.08B | 2B | 2.17B | 2.22B | 2.33B | 2.31B | 2.32B | 2.35B | 2.33B | 2.37B | 2.34B | 2.72B | 2.65B | 2.56B | 2.48B |
Account Payables | 42.06M | 44.12M | 46.43M | 47.37M | 32M | 31.64M | 34.59M | 31.7M | 30.99M | 35.33M | 31.86M | 27.14M | 30.23M | 30.32M | 36.65M | 34.36M | 40.66M | 59.07M |
Deferred Revenue | n/a | n/a | n/a | n/a | -310.16M | -247.28M | n/a | -31.7M | -30.99M | n/a | 105.92M | n/a | 93.22M | n/a | 88.34M | 39.4M | 35.67M | 46.91M |
Short-Term Debt | 23.68M | 22.13M | 18.75M | 19.28M | 36.49M | 16.41M | 35.99M | 36.74M | 36.49M | 35.97M | 12.5M | n/a | 14.92M | 23.29M | n/a | 21.73M | 21.19M | 20.55M |
Other Current Liabilities | n/a | n/a | 2.17M | 17.34M | 79.77M | 86.01M | 65.22M | 74.81M | 83.2M | 95.73M | 125.83M | 122.2M | 42M | 87.79M | 46.07M | 99.31M | 104.83M | 105.37M |
Total Current Liabilities | 341.04M | 271.05M | 434.11M | 373.08M | 310.16M | 207.03M | 388.95M | 350.44M | 320.32M | 226.68M | 374.23M | 351.69M | 287.46M | 269.73M | 394.12M | 397.56M | 351.11M | 326.96M |
Long-Term Debt | 583.86M | 590.48M | 593.57M | 607.45M | 612.64M | 693.35M | 611.59M | 621.69M | 666.27M | 742.81M | 627.65M | 731M | 793.25M | 804.93M | 1B | 1B | 996.64M | 996.86M |
Other Long-Term Liabilities | 277.46M | 277.8M | 290.34M | 288.3M | 286.29M | 289.36M | 281.84M | 296.71M | 295.71M | 306.57M | 315.04M | 305.13M | 316.39M | 308.95M | 313.43M | 308.54M | 309.85M | 293.34M |
Total Long-Term Liabilities | 927.3M | 933.24M | 953.65M | 971.3M | 978.73M | 1.1B | 981.8M | 1.01B | 1.04B | 1.18B | 1.08B | 1.12B | 1.24B | 1.19B | 1.43B | 1.4B | 1.39B | 1.39B |
Total Liabilities | 1.27B | 1.2B | 1.39B | 1.34B | 1.29B | 1.31B | 1.37B | 1.36B | 1.36B | 1.41B | 1.46B | 1.47B | 1.52B | 1.46B | 1.83B | 1.8B | 1.75B | 1.72B |
Total Debt | 649.56M | 655.32M | 662.31M | 683.65M | 698.31M | 778.66M | 701.65M | 706.92M | 745.83M | 822.76M | 753.57M | 814.14M | 906.38M | 869.21M | 1.07B | 1.07B | 1.06B | 1.06B |
Common Stock | 869K | 858K | 859K | 859K | 858K | 840K | 840K | 839K | 838K | 836K | 829K | 830K | 841K | 872K | 864K | 864K | 863K | 862K |
Retained Earnings | -188.54M | -227.8M | -248.54M | -279.02M | -298.46M | -145.44M | -149.47M | -25.18M | -46.58M | -74.86M | -89.06M | -118.72M | -149.45M | -176.59M | -155.39M | -202.91M | -233.7M | -268.71M |
Comprehensive Income | 137K | -292K | -1.07M | -209K | -1.95M | -2.15M | -2.21M | -3.52M | -3.52M | -3.13M | -3.73M | -4.1M | -2.58M | -1.35M | 1.32M | 2.22M | 2.51M | 2.4M |
Shareholders Equity | 833.75M | 789.19M | 764.94M | 732.49M | 706.46M | 856.2M | 849.06M | 967.99M | 942.38M | 909.77M | 891.63M | 858.67M | 845.43M | 877.08M | 896.69M | 845.47M | 808.91M | 766.76M |
Total Investments | 123.59M | 120.2M | 118.57M | 116.62M | 143.19M | 107.47M | 104.48M | 103.54M | 98.49M | 96.71M | 186.48M | 91.4M | 186.77M | 89.58M | 199.43M | 98.51M | 100.76M | 100.81M |